Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Swan

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Family Practice|April 20, 2010
Transforming strategies for the prevention of chronic HBV and HCV infectionsJohn W Ward, Dale J Hu, Miriam J Alter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Recommendations for the management of hepatitis C virus infection among people who inject drugsGeert Robaeys, Jason Grebely, Stefan Mauss, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy|January 11, 2016
Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The Lancet. Gastroenterology & Hepatology|July 31, 2020
Global hepatitis C elimination: an investment frameworkAlisa Pedrana, Jessica Howell, Nick Scott, et al.
The International Journal on Drug Policy|June 19, 2017
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE studyJason Grebely, Olav Dalgard, Evan B Cunningham, et al.
BMC Infectious Diseases|June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE studyEvan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 22, 2019
Innovative strategies for the elimination of viral hepatitis at a national level: A country case seriesSophia E Schröeder, Alisa Pedrana, Nick Scott, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Family Practice|April 20, 2010
Transforming strategies for the prevention of chronic HBV and HCV infectionsJohn W Ward, Dale J Hu, Miriam J Alter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Recommendations for the management of hepatitis C virus infection among people who inject drugsGeert Robaeys, Jason Grebely, Stefan Mauss, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy|January 11, 2016
Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The Lancet. Gastroenterology & Hepatology|July 31, 2020
Global hepatitis C elimination: an investment frameworkAlisa Pedrana, Jessica Howell, Nick Scott, et al.
The International Journal on Drug Policy|June 19, 2017
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE studyJason Grebely, Olav Dalgard, Evan B Cunningham, et al.
BMC Infectious Diseases|June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE studyEvan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 22, 2019
Innovative strategies for the elimination of viral hepatitis at a national level: A country case seriesSophia E Schröeder, Alisa Pedrana, Nick Scott, et al.
Pageof 5